` Comparison: LUCD, BSX - Alpha Spread

L
LUCD
vs
BSX

Over the past 12 months, LUCD has significantly outperformed BSX, delivering a return of +45% compared to the BSX's +2% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
LUCD
BSX
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

LUCD Intrinsic Value
HIDDEN
Show
BSX Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
L
Lucid Diagnostics Inc
NASDAQ:LUCD
1.14 USD
Boston Scientific Corp
NYSE:BSX
91.75 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
LUCD, BSX

LUCD
BSX
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
L
Lucid Diagnostics Inc
Revenue
Boston Scientific Corp
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
LUCD, BSX

LUCD
BSX
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
L
Lucid Diagnostics Inc
NASDAQ:LUCD
Boston Scientific Corp
NYSE:BSX
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

LUCD
-58.1%
BSX
68.6%

Operating Margin

LUCD
-1 091.3%
BSX
19.4%

Net Margin

LUCD
-1 496.8%
BSX
14.4%

FCF Margin

LUCD
-1 004.4%
BSX
19.8%

ROE

LUCD
-409.3%
BSX
12.7%

ROA

LUCD
-173.7%
BSX
6.9%

ROIC

LUCD
-794.2%
BSX
8.5%

ROCE

LUCD
-271.7%
BSX
10.8%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
LUCD, BSX

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
LUCD, BSX

Performance Gap Between LUCD and BSX
HIDDEN
Show

Performance By Year
LUCD, BSX

Loading
LUCD
BSX
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare LUCD to other stocks
Unlock Full Access to Alpha Spread
Create Free Account